BLOG / 🇺🇸 United States / broad market · · monthly

US Pre-Market SEC Filings Roundup — July 01, 2026

USA Before-Market Intelligence

By Gunpowder Editorial ·

24 high priority 26 medium priority 50 total filings analysed

Executive Summary

Overnight SEC filings from June 30 to July 1, 2026, reveal a market dominated by capital return programs, SPAC extension maneuvers, and a significant biotech acquisition. A clear theme of aggressive shareholder returns emerges, with Aegon launching a new EUR 200 million buyback and Sumitomo Mitsui executing a large JPY 76 billion repurchase, though lagging its authorization pace.

The SPAC space shows continued stress, with Plum Acquisition Corp. IV seeking a shareholder vote to extend its business combination deadline, offering non-redemption incentives. The most material event is the completed acquisition of Aptose Biosciences by Hanmi Pharmaceuticals for C$2.41 per share, a definitive end for the biotech. On the negative side, InnSuites Hospitality Trust received a NYSE American delisting notice due to a stockholders' deficit, while Terra Innovatum Global reported a sharply widening net loss, though it holds a strong cash position. Insider activity was mixed, with a notable open-market purchase by a Hallador Energy director signaling confidence in the energy sector, countered by a large sale by a United Microelectronics Corp vice president. Overall, the filings point to a bifurcated market: established companies returning capital to shareholders, while earlier-stage and stressed entities focus on survival and restructuring.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4 · S-1 · DEFA14A · 8-K · 10-Q

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from June 24, 2026.

Investment Signals (10)

  • Aegon Ltd. ↓ (BULLISH)
    ▲

    Launched a new EUR 200M buyback program (following a completed EUR 227M buyback at avg EUR 6.68/share), with a clear commitment to cancel all repurchased shares, signaling strong capital return discipline and management confidence in intrinsic value

  • Hallador Energy Co ↓ (BULLISH)
    ▲

    Director Hudson Daniel Timothy bought 10,000 shares total (~$169.4K) at ~$16.94, a significant open-market purchase by a board member, indicating strong insider conviction in the company's prospects amid the energy sector

  • Sumitomo Mitsui Financial Group ↓
    ▲

    Repurchased 12.2M shares for ~$506M in June, but this represents only ~30% of its 40M share authorization with the program ending July 31, suggesting execution is behind schedule and may signal either a lack of urgency or a strategic pause [NEUTRAL/BEARISH]

  • Navios Maritime Partners ↓ (BULLISH)
    ▲

    CEO Frangou Angeliki bought 3,602 common units (~$249K) under a 10b5-1 plan, a pre-planned but still positive signal of insider alignment with shareholders at current price levels (~$69)

  • United Microelectronics Corp ↓ (BEARISH)
    ▲

    Vice President HU CHE-JEN sold 10,000 shares for ~$1.71M at $171.30, a large, discretionary sale by a senior insider, which could indicate profit-taking or a bearish view on near-term valuation

  • Mizuho Financial Group ↓ (BULLISH)
    ▲

    Announced a ¥100B share repurchase program for up to 25M shares (1.0% of outstanding), a significant capital return initiative that, combined with its AGM results showing some director dissent (75% approval for one nominee), presents a mixed but overall positive capital allocation signal

  • Aptose Biosciences ↓ (NEUTRAL)
    ▲

    Acquisition by Hanmi Pharmaceuticals completed at C$2.41/share, providing a clear exit for shareholders. The deal's completion removes uncertainty but offers no further upside for remaining holders

  • Terra Innovatum Global ↓ (MIXED)
    ▲

    Q1 2026 net loss widened to $7.1M from $1.4M YoY, driven by a surge in G&A to $5.4M and development costs to $1.2M. However, cash position soared to $96.7M from $44, providing a massive runway despite the cash burn, creating a high-risk, high-reward scenario

  • HIVE Digital Technologies ↓ (BULLISH)
    ▲

    Priced a upsized $115M 0% exchangeable senior notes offering due 2031, with proceeds for GPU purchases and data center development. The 125% premium cap price ($8.53 vs $3.79 closing) shows management is actively managing dilution, a positive signal for existing shareholders

  • Prestige Wealth Inc. (now Aurelion Inc.) ↓ (BULLISH)
    ▲

    Announced a complete leadership transition with new Chairman, CEO, and independent director, all with deep digital assets and institutional investment experience. This signals a strategic pivot and potential for a new growth trajectory

Risk Flags (8)

  • InnSuites Hospitality Trust/Delisting Risk↓ [HIGH RISK]
    ▼

    Received NYSE American delisting notice due to a $(921,921) stockholders' deficit and net losses in 2 of 3 recent fiscal years. Must submit a compliance plan by July 24, 2026, or face delisting, creating existential risk for the stock

  • Plum Acquisition Corp. IV/SPAC Extension Risk↓ [HIGH RISK]
    ▼

    Calling an extraordinary general meeting on July 10 to extend its business combination deadline to Jan 2027. The need for an extension and non-redemption agreements signals difficulty in finding a deal, with high risk of liquidation if the vote fails

  • Terra Innovatum Global/Widening Losses↓ [HIGH RISK]
    ▼

    Q1 2026 net loss of $7.1M is 5x larger than the $1.4M loss in Q1 2025, driven by a 4x increase in G&A expenses to $5.4M. While cash is ample, the burn rate is accelerating sharply without corresponding revenue, a classic cash-burning red flag

  • Stewards, Inc./Failed IPO & Compensation Risk↓ [HIGH RISK]
    ▼

    Filed amended S-1 but is no longer actively pursuing a Nasdaq listing. Issued 250,000 RSUs to six executives with no compensation expense recognized because vesting conditions are not deemed probable, indicating a high likelihood of failure to meet performance targets

  • Sumitomo Mitsui Financial Group/Buyback Execution Lag↓ [MEDIUM RISK]
    ▼

    Repurchased only 30% of its authorized 40M shares with the program ending July 31. This slow execution could imply management sees limited value at current prices or is conserving capital for other uses, creating uncertainty around the program's completion

  • Hartman vREIT XXI/NAV Sensitivity↓ [MEDIUM RISK]
    ▼

    Estimated NAV of $8.12/share is highly sensitive to cap rates; a 2.5% increase in cap rates would drop NAV to $7.18. The NAV also excludes a liquidity discount for untraded shares, meaning actual realizable value could be significantly lower

  • Mizuho Financial Group/Governance Risk↓ [MEDIUM RISK]
    ▼

    At its AGM, director Takakazu Uchida received only 75% approval, with over 4.4M disapproval votes. While still elected, this level of dissent signals potential governance concerns or shareholder dissatisfaction with specific board members

  • Encore Medical/High-Risk IPO↓ [HIGH RISK]
    ▼

    Filing for a $15M IPO at $5/share with no public market and as an emerging growth company. While the PFO market is large ($1.5B), the ASD market is small, and the company has significant operating losses and risks typical of early-stage medtech

Opportunities (8)

  • Aegon Ltd./Capital Return Catalyst↓ (OPPORTUNITY)
    ◆

    New EUR 200M buyback program running until Dec 23, 2026, with all shares to be cancelled. Combined with the completed EUR 227M buyback at avg EUR 6.68, this provides a clear floor and ongoing catalyst for share price appreciation

  • Hallador Energy/Insider Confidence↓ (OPPORTUNITY)
    ◆

    Director bought $169K in open market at ~$16.94. With energy prices supportive and a clear insider vote of confidence, this could signal a turnaround or undervaluation in the coal/natural gas space

  • HIVE Digital Technologies/Dilution-Managed Growth↓ (OPPORTUNITY)
    ◆

    The $115M 0% note offering with a capped call at $8.53 (125% premium) provides cheap capital for GPU/data center expansion while limiting dilution. If Bitcoin/high-performance computing demand stays strong, this is a well-structured growth financing

  • Terra Innovatum Global/Cash-Rich Turnaround↓ (OPPORTUNITY)
    ◆

    Despite widening losses, the company has $96.7M in cash vs $44 a year ago. If the company can control expenses and execute on its business plan, the massive cash runway provides a multi-year opportunity to reach profitability or be acquired

  • Encore Medical/Structural Heart IPO↓ (OPPORTUNITY)
    ◆

    IPO at $5/share targeting $15M gross proceeds for a company with 35,000+ implants outside the U.S. and CE Mark approval. The $1.5B PFO market opportunity and NYSE American listing (EMI) could attract early-stage medtech investors

  • Prestige Wealth Inc./New Leadership Catalyst↓ (OPPORTUNITY)
    ◆

    Complete overhaul of management with deep digital assets and M&A experience. The strategic pivot could unlock value if the new team executes on a credible growth plan, making this a high-risk, high-reward special situation

  • Navios Maritime Partners/CEO 10b5-1 Buying↓ (OPPORTUNITY)
    ◆

    CEO buying ~$249K in units under a pre-planned program. While not discretionary, it still shows alignment. With the stock at ~$69, the shipping cycle could provide upside if rates remain supportive

  • DDC Enterprise/Strong Shareholder Support↓ (OPPORTUNITY)
    ◆

    All four director nominees received overwhelming support (99.98% for) at the AGM, indicating strong shareholder alignment. Combined with a new $10M buyback program (potentially using Bitcoin as collateral), this shows a proactive management team

Sector Themes (6)

  • Financial Sector Capital Returns
    ◆

    Three major financial institutions (Mizuho, Sumitomo Mitsui, Aegon) announced or executed significant buyback programs totaling over $1.5B. This signals a sector-wide trend of returning excess capital to shareholders, driven by strong balance sheets and regulatory clarity. Investors should favor banks with active buyback programs.

  • SPAC Extension Wave
    ◆

    Plum Acquisition Corp. IV's extension vote highlights ongoing stress in the SPAC market. With a July 10 vote and non-redemption incentives, this is part of a broader pattern of SPACs struggling to find deals before deadlines, creating both liquidation risk and potential for distressed deal-making.

  • Biotech M&A Exit
    ◆

    The Aptose Biosciences acquisition by Hanmi Pharmaceuticals at C$2.41/share provides a clean exit for a small-cap biotech. This deal, along with the Encore Medical IPO filing, shows that the biotech sector remains active for M&A exits and capital formation, though risk is high for early-stage names.

  • Energy Insider Conviction
    ◆

    Hallador Energy's director purchase contrasts with the broader market, suggesting selective insider confidence in the energy sector. While not a broad trend, this single data point is worth monitoring for further insider buying in the space, which could signal a sector bottom or undervaluation.

  • Tech Hardware Growth Financing
    ◆

    HIVE Digital's $115M note offering for GPU/data center expansion is a microcosm of the broader trend in tech hardware (semiconductors, data centers) where companies are raising cheap debt to fund AI-related capital expenditures, betting on future demand growth.

  • REIT Distress Signals
    ◆

    InnSuites Hospitality Trust's delisting notice and Hartman vREIT's NAV sensitivity to cap rates highlight stress in the REIT sector, particularly for smaller, non-traded or highly leveraged names. Rising interest rates and cap rate expansion are creating valuation and compliance risks.

Watch List (8)

  • InnSuites Hospitality Trust↓
    👁

    Must submit a compliance plan to NYSE American by July 24, 2026. Watch for the plan details, which may include debt-to-equity conversion or capital raises. Failure to submit or a rejected plan could lead to delisting.

  • Plum Acquisition Corp. IV↓
    👁

    Extraordinary general meeting on July 10, 2026, to vote on business combination extension. Redemption deadline is July 8. The outcome will determine whether the SPAC survives or liquidates.

  • Sumitomo Mitsui Financial Group↓
    👁

    Buyback program ends July 31, 2026. With only 30% of authorization executed by June 30, watch for accelerated repurchases in July or an announcement of program completion/extension.

  • Aegon Ltd.↓
    👁

    New EUR 200M buyback runs until Dec 23, 2026. Monitor monthly buyback announcements for pace and execution, which will signal management's view on valuation.

  • Stewards, Inc.↓
    👁

    No longer actively pursuing Nasdaq listing. Watch for any new listing plans, alternative liquidity events, or revisions to RSU vesting conditions that could signal a change in strategy.

  • Encore Medical, Inc.↓
    👁

    IPO expected to price soon, with NYSE American listing under 'EMI'. Watch for the final IPO price and first-day trading performance to gauge investor appetite for structural heart medtech.

  • HIVE Digital Technologies↓
    👁

    The $115M note offering closed. Watch for deployment of proceeds into GPU purchases and data center development, which will be key to future revenue growth.

  • Terra Innovatum Global↓
    👁

    Q1 2026 results show widening losses but strong cash. Watch for Q2 2026 results to see if the expense surge is temporary or a new run-rate, and for any revenue generation milestones.

Filing Analyses (50)
McEwen Inc. 4 neutral materiality 5/10

30-06-2026

Chief Financial Officer Ing Perry exercised/converted 270 Common Stock. 10 transactions reported in total. Ing Perry holds 48,094 shares after the transaction.

  • · Chief Financial Officer Ing Perry exercised/converted 270 Common Stock
  • · Chief Financial Officer Ing Perry exercised/converted 116 Common Stock
  • · Chief Financial Officer Ing Perry exercised/converted 686 Common Stock
  • · Chief Financial Officer Ing Perry exercised/converted 337 Common Stock
  • · Chief Financial Officer Ing Perry exercised/converted 91 Common Stock
  • · Chief Financial Officer Ing Perry exercised/converted 1,866 Restricted Stock Units
  • · Chief Financial Officer Ing Perry exercised/converted 800 Restricted Stock Units
  • · Chief Financial Officer Ing Perry exercised/converted 4,740 Restricted Stock Units
Bitfarms Ltd 4 neutral materiality 6/10

30-06-2026

Chief Executive Officer Gagnon Benjamin disposed to the issuer 500,000 Stock Options (Right to Buy).

  • · Chief Executive Officer Gagnon Benjamin disposed to the issuer 500,000 Stock Options (Right to Buy)
  • · Chief Executive Officer Gagnon Benjamin was awarded 500,000 Stock Options (Right to Buy)
McEwen Inc. 4/A neutral materiality 4/10

30-06-2026

VP - Finance Chan Jeffrey exercised/converted 248 Common Stock. This amends a previously filed Form 4. Chan Jeffrey holds 3,939 shares after the transaction.

  • · VP - Finance Chan Jeffrey exercised/converted 248 Common Stock
  • · VP - Finance Chan Jeffrey exercised/converted 533 Restricted Stock Units
HALLADOR ENERGY CO 4 positive materiality 6/10

30-06-2026

Director Hudson Daniel Timothy bought 5,000 COMMON STOCK at $16.98 (~$84.9K). Hudson Daniel Timothy holds 15,000 shares after the transaction.

  • · Director Hudson Daniel Timothy bought 5,000 COMMON STOCK at $16.90 (~$84.5K)
  • · Director Hudson Daniel Timothy bought 5,000 COMMON STOCK at $16.98 (~$84.9K)
Navios Maritime Partners L.P. 4 positive materiality 2/10

30-06-2026

See Remarks Frangou Angeliki bought 1,199 Common Unit at $69.50 (~$83.3K). Frangou Angeliki holds 4,758,618 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · See Remarks Frangou Angeliki bought 1,195 Common Unit at $69.22 (~$82.7K)
  • · See Remarks Frangou Angeliki bought 1,208 Common Unit at $68.88 (~$83.2K)
  • · See Remarks Frangou Angeliki bought 1,199 Common Unit at $69.50 (~$83.3K)
PROVECTUS BIOPHARMACEUTICALS, INC. 4 neutral materiality 4/10

30-06-2026

Director Bailey Webster was awarded 48,917 Series D-1 Convertible Preferred Stock.

  • · Director Bailey Webster was awarded 48,917 Series D-1 Convertible Preferred Stock
McEwen Inc. 4 neutral materiality 4/10

30-06-2026

VP - Finance Chan Jeffrey exercised/converted 588 Common Stock. 4 transactions reported in total. Chan Jeffrey holds 4,775 shares after the transaction.

  • · VP - Finance Chan Jeffrey exercised/converted 588 Common Stock
  • · VP - Finance Chan Jeffrey exercised/converted 248 Common Stock
  • · VP - Finance Chan Jeffrey exercised/converted 1,266 Restricted Stock Units
  • · VP - Finance Chan Jeffrey exercised/converted 533 Restricted Stock Units
INTERNATIONAL ISOTOPES INC 4 neutral materiality 3/10

30-06-2026

Director GROSSO CHRISTOPHER G bought 0 Convertible Promissory Note at $500,000.00.

  • · Director GROSSO CHRISTOPHER G bought 0 Convertible Promissory Note at $500,000.00
McEwen Inc. 4 neutral materiality 5/10

30-06-2026

Director Ball Ian J exercised/converted 160 Common Stock. Ball Ian J holds 320 shares after the transaction.

  • · Director Ball Ian J exercised/converted 160 Common Stock
  • · Director Ball Ian J exercised/converted 310 Restricted Stock Units
McEwen Inc. 4 neutral materiality 4/10

30-06-2026

General Counsel/Corp Sec Diges Carmen L exercised/converted 1,300 Restricted Stock Units. 5 transactions reported in total.

  • · General Counsel/Corp Sec Diges Carmen L exercised/converted 1,300 Restricted Stock Units
  • · General Counsel/Corp Sec Diges Carmen L exercised/converted 533 Restricted Stock Units
  • · General Counsel/Corp Sec Diges Carmen L exercised/converted 3,370 Restricted Stock Units
  • · General Counsel/Corp Sec Diges Carmen L exercised/converted 1,470 Restricted Stock Units
  • · General Counsel/Corp Sec Diges Carmen L exercised/converted 380 Restricted Stock Units
McEwen Inc. 4 neutral materiality 5/10

30-06-2026

Chief Operating Officer Shaver William M exercised/converted 2,100 Common Stock. 10 transactions reported in total. Shaver William M holds 171,086 shares after the transaction.

  • · Chief Operating Officer Shaver William M exercised/converted 2,100 Common Stock
  • · Chief Operating Officer Shaver William M exercised/converted 866 Common Stock
  • · Chief Operating Officer Shaver William M exercised/converted 11,740 Common Stock
  • · Chief Operating Officer Shaver William M exercised/converted 5,700 Common Stock
  • · Chief Operating Officer Shaver William M exercised/converted 1,480 Common Stock
  • · Chief Operating Officer Shaver William M exercised/converted 2,100 Restricted Stock Units
  • · Chief Operating Officer Shaver William M exercised/converted 866 Restricted Stock Units
  • · Chief Operating Officer Shaver William M exercised/converted 11,740 Restricted Stock Units
McEwen Inc. 4 neutral materiality 4/10

30-06-2026

VP Corporate Development Spears Stephan Michael exercised/converted 1,200 Restricted Stock Units.

  • · VP Corporate Development Spears Stephan Michael exercised/converted 1,200 Restricted Stock Units
  • · VP Corporate Development Spears Stephan Michael exercised/converted 500 Restricted Stock Units
PROVECTUS BIOPHARMACEUTICALS, INC. 4 neutral materiality 3/10

30-06-2026

PRESIDENT Rodrigues Dominic was awarded 45,860 Series D-1 Convertible Preferred Stock.

  • · PRESIDENT Rodrigues Dominic was awarded 45,860 Series D-1 Convertible Preferred Stock
PROVECTUS BIOPHARMACEUTICALS, INC. 4 neutral materiality 4/10

30-06-2026

Director Lacey John III was awarded 48,917 Series D-1 Convertible Preferred Stock.

  • · Director Lacey John III was awarded 48,917 Series D-1 Convertible Preferred Stock
Ultra Clean Holdings, Inc. 4 neutral materiality 4/10

30-06-2026

Chief Accounting Officer HARDING BRIAN E was awarded 9,363 Common Stock. HARDING BRIAN E holds 37,418 shares after the transaction.

  • · Chief Accounting Officer HARDING BRIAN E was awarded 9,363 Common Stock
Aeries Technology, Inc. 4 neutral materiality 6/10

30-06-2026

Chief Executive Officer Khare Bhisham was awarded 125,000 Stock Option (Right to Buy).

  • · Chief Executive Officer Khare Bhisham was awarded 125,000 Stock Option (Right to Buy)
UNITED MICROELECTRONICS CORP 4 negative materiality 4/10

30-06-2026

Vice President HU CHE-JEN sold 10,000 Common Shares at $171.30 (~$1.71M). HU CHE-JEN holds 3,214,080 shares after the transaction.

  • · Vice President HU CHE-JEN sold 10,000 Common Shares at $171.30 (~$1.71M)
Quantum eMotion Corp 6-K neutral materiality 2/10

01-07-2026

Quantum eMotion Corp. filed a Form 6-K with the SEC on June 30, 2026, announcing its sponsorship of the AI for Good Global Summit and participation in a cybersecurity panel. The filing is a routine disclosure of a press release by the foreign private issuer, with no financial results or material operational changes reported.

  • · The filing is a Form 6-K for the month of June 2026 under Commission File Number 001-43068.
  • · The company's principal executive office is located at 2300 Alfred Nobel, Montreal, Québec, Canada H4S 2A4.
  • · The company files annual reports under Form 40-F (Canadian issuer).
  • · The news release dated June 30, 2026, announces sponsorship of the AI for Good Global Summit and participation in a cybersecurity panel.
DDC Enterprise Ltd 6-K positive materiality 3/10

01-07-2026

DDC Enterprise Ltd reported the voting results from its annual meeting, with all four director nominees receiving overwhelming support. Norma Ka Yin Chu, George Lai, Matthew Gene Mouw, and Samuel Chun Kong Shih each garnered 37,289,886 votes for, with only 7,102 against and 166,739 abstentions, indicating strong shareholder approval.

MIZUHO FINANCIAL GROUP INC 6-K neutral materiality 2/10

01-07-2026

Mizuho Financial Group disclosed a planned additional trust contribution to an existing officer share distribution trust on July 14, 2026. The trust is a third-party beneficiary trust with Mizuho Trust & Banking as trustee, benefiting eligible directors and executives across the group.

  • · The trust is a monetary trust held in a form other than monetary trust (third party beneficiary trust).
  • · Beneficiaries include directors and executive officers of the Company and its subsidiaries Mizuho Bank, Mizuho Trust & Banking, and Mizuho Securities.
  • · The additional trust date is planned for July 14, 2026.
ECOPETROL S.A. 6-K neutral materiality 1/10

01-07-2026

Ecopetrol S.A. filed a Form 6-K with the SEC for July 2026, confirming its status as a foreign private issuer under Rule 13a-16 or 15d-16. The report was signed by Chief Financial Officer Alfonso Camilo Barco and indicates the company files annual reports under Form 20-F. No financial results or material business updates were included in this filing.

  • · Filing is a routine SEC Form 6-K for the month of July 2026.
  • · Commission File Number: 001-34175.
  • · Company address: Carrera 13 No. 36 – 24, Bogotá D.C., Colombia.
  • · Ecopetrol files annual reports under Form 20-F, not Form 40-F.
AEGON LTD. 6-K mixed materiality 7/10

01-07-2026

Aegon Ltd. announced the commencement of a EUR 200 million share buyback program, following the completion of its prior EUR 227 million buyback on June 30, 2026. The new program, unveiled at the Capital Markets Day on December 10, 2025, is expected to run until December 23, 2026, with Vereniging Aegon (holding ~18.4% voting rights) participating pro-rata for EUR 37 million. The completed buyback repurchased 33,909,553 common shares at an average price of EUR 6.68 per share, with 4,033,295 shares (EUR 27 million) reserved for share-based compensation plans and the remainder to be cancelled.

  • · The new buyback is executed under the authority granted at the AGM on June 10, 2026.
  • · The buyback complies with EU Market Abuse Regulation.
  • · Aegon intends to cancel all shares repurchased under the new program.
  • · The completed buyback spanned from January 12, 2026, to June 30, 2026.
  • · Of the 33,909,553 repurchased shares, 29,876,258 will be cancelled (remainder after compensation plan allocation).
  • · Vereniging Aegon's participation is based on its combined common shares and common shares B.
MIZUHO FINANCIAL GROUP INC 6-K positive materiality 6/10

01-07-2026

Mizuho Financial Group Inc. announced a share repurchase program authorizing the buyback of up to 25 million shares (1.0% of outstanding shares) for a maximum aggregate price of ¥100 billion. The repurchase period runs from May 18, 2026 to August 31, 2026, and will be executed via market purchases using a trust method.

  • · Repurchase method: market purchase utilizing trust method
  • · Repurchase period: May 18, 2026 to August 31, 2026
HONDA MOTOR CO LTD 6-K positive materiality 5/10

01-07-2026

Honda Motor Co Ltd held its annual general meeting where all 11 director nominees were approved by shareholders. Toshihiro Mibe received the lowest affirmative vote ratio at 90.08%, while Mahito Shikama received the highest at 96.90%. All directors were elected with strong majority support.

  • · Total affirmative votes ranged from 28,870,166 (Mibe) to 31,058,828 (Shikama).
  • · Negative votes ranged from 868,573 (Nagata) to 2,467,007 (Mibe).
  • · Abstentions were 610,630 for most nominees, except Kokubu (625,928) and Shikama (101).
Suzano S.A. 6-K neutral materiality 5/10

01-07-2026

Suzano S.A. filed a Form 6-K with the SEC on July 1, 2026, announcing the closing of a joint venture transaction with Kimberly-Clark. The filing was signed by Vice-President of Finance and Investor Relations Marcos Moreno Chagas Assumpção. No financial details or performance metrics were disclosed in the filing.

  • · The filing is a Form 6-K for the month of July 2026 under Commission File Number 001-38755.
  • · The registrant's address is Av. Professor Magalhaes Neto, 1,752, 10th Floor, Rooms 1010 and 1011, Salvador, Brazil 41 810-012.
  • · The registrant files annual reports under Form 20-F.
SUMITOMO MITSUI FINANCIAL GROUP, INC. 6-K neutral materiality 5/10

01-07-2026

Sumitomo Mitsui Financial Group disclosed repurchases of its common stock during June 2026, buying back 12,175,400 shares for JPY 76,119,941,100 (approx. $506M USD). This was part of an ongoing buyback program authorizing up to 40,000,000 shares and JPY 180,000,000,000 by July 31, 2026; however, as of June 30 the aggregate number repurchased represents only ~30% of the authorized share count, suggesting execution may lag behind the original timeline.

  • · Repurchase method: Market purchases based on a discretionary dealing contract.
  • · The program began May 14, 2026 and ends July 31, 2026.
  • · The 12,175,400 shares repurchased in June represent approximately 30% of the 40,000,000 share authorization.
  • · The amount spent in June (¥76.1B) is about 42% of the total authorized ¥180.0B.
Encore Medical, Inc. S-1/A neutral materiality 8/10

01-07-2026

Encore Medical, Inc. filed Amendment No. 5 to its S-1 registration statement for an initial public offering of 3,000,000 shares of common stock at an expected price of $5.00 per share, targeting gross proceeds of $15.0 million. The company is a structural heart device firm focused on transcatheter closure of cardiac defects, with over 35,000 implants outside the U.S. and CE Mark approval. However, the company has no public market for its stock, faces high risk as an emerging growth and smaller reporting company, and its primary PFO market is estimated at $1.5 billion annually, though the ASD market is small and not a primary focus.

  • · The company has elected to comply with reduced reporting requirements as an emerging growth company and smaller reporting company.
  • · The offering is contingent on listing on NYSE American under symbol 'EMI'.
  • · Underwriters have a 45-day option to purchase up to 450,000 additional shares to cover over-allotments.
  • · The company has obtained CE Mark approval for its products and markets them through distribution partners outside the U.S.
  • · The ASD market is described as small and not a primary focus of the company.
  • · The company was founded in 2017 but builds on over two decades of experience with more than 35,000 implants.
MIZUHO FINANCIAL GROUP INC 6-K neutral materiality 5/10

01-07-2026

Mizuho Financial Group Inc. held its annual general meeting where shareholders voted on the appointment of 14 directors. All nominees were adopted, with approval rates ranging from 75% to 99%. Notably, Takakazu Uchida received the lowest approval rate at 75%, while Masahiro Kihara and Hidekatsu Take also saw relatively lower support at 82% and 83%, respectively.

  • · Takakazu Uchida received 4,398,147 disapproval votes, the highest among all nominees.
  • · Masahiro Kihara received 3,152,998 disapproval votes.
  • · Hidekatsu Take received 3,021,225 disapproval votes.
  • · All 14 director appointments were adopted as proposed.
DDC Enterprise Ltd 6-K neutral materiality 4/10

01-07-2026

DDC Enterprise Ltd announced a share repurchase program approved by its board on June 9, 2026, authorizing up to $10,000,000 in buybacks of Class A ordinary shares (or up to 20% of outstanding shares, whichever is lower) over 18 months, with the program potentially using Bitcoin as collateral for financing. The program is discretionary and may be modified or discontinued at any time. No immediate financial impact is reported, and the announcement does not disclose current share price, outstanding shares, or repurchase history.

  • · Share repurchase program authorized for up to 18 months from June 9, 2026
  • · Repurchases may be conducted via Rule 10b5-1 trading plans, open market purchases, or other permissible means
  • · Program funding will come from available free cash flow and operating cash; financing may use Bitcoin as collateral
  • · Quarterly board review of capital allocation required
  • · The program does not obligate the company to repurchase any specific number of shares
AngloGold Ashanti PLC 6-K neutral materiality 2/10

01-07-2026

AngloGold Ashanti plc filed a Form 6-K with the SEC on July 1, 2026, for the month of July 2026, primarily to furnish a Notice of General Meeting as an exhibit. The filing is standard for a foreign private issuer and does not contain detailed financial results or material business updates.

DIAGEO PLC 6-K neutral materiality 1/10

01-07-2026

Diageo plc filed a Form 6-K reporting multiple routine share transactions by members of its Executive Committee. Hannah Brooks received 21.51 American Depositary Shares via a dividend reinvestment plan, while Hina Nagarajan received 302.63 ordinary shares under the same plan. Other executives (Randall Ingber, Dayalan Nayager, John O'Keeffe, Louise Prashad) purchased small lots of partnership shares and received matching shares under employee share incentive plans. All transactions are standard, non-discretionary, and immaterial in size, reflecting no change in corporate outlook or strategy.

  • · All transactions were executed on either the New York Stock Exchange (XNYS) or the London Stock Exchange (XLON), with matching shares awarded outside a trading venue.
  • · The filing is a routine notification under UK Market Abuse Regulation and does not indicate any change in beneficial ownership or corporate strategy.
  • · No aggregated transaction information was provided (marked as N/A) for any of the six PDMRs.
ALTERITY THERAPEUTICS LTD 6-K neutral materiality 2/10

01-07-2026

Alterity Therapeutics Ltd filed a Form 6-K with the SEC on July 1, 2026, submitting an application for quotation of securities (ATH). This administrative filing relates to the listing of additional securities on an Australian exchange, with no financial results or operational updates disclosed.

  • · The filing is a foreign issuer report (Form 6-K) and incorporates by reference into multiple SEC registration statements on Forms S-8 and F-3.
  • · The securities quotation application is for ATH (likely the ticker on the Australian Securities Exchange).
ELBIT SYSTEMS LTD 6-K neutral materiality 1/10

01-07-2026

Elbit Systems Ltd. filed a Form 6-K with the SEC on July 1, 2026, announcing that its proxy statement and proxy card will be mailed to shareholders on or about July 8, 2026. The filing does not contain any financial results or operational updates.

  • · Proxy statement and proxy card to be mailed on or about July 8, 2026.
  • · Filing is a procedural report of a foreign private issuer under Rule 13a-16 or 15d-16.
SOUTHERN CALIFORNIA GAS CO DEFA14A neutral materiality 3/10

01-07-2026

Southern California Gas Company (SoCalGas) has scheduled a Special Meeting of Shareholders for August 6, 2026, and is urging shareholders to vote before the meeting. The company has engaged D.F. King as proxy information administrator to facilitate voting via a toll-free number. No specific agenda items or financial details are disclosed in this filing.

  • · Special Meeting of Shareholders scheduled for Thursday, August 6, 2026.
  • · Shareholders can vote by calling D.F. King toll-free at 1-800-769-7666, Monday through Friday, 9:00 a.m. to 10:00 p.m. Eastern time.
  • · No fee is required for this filing.
  • · The filing is categorized as Definitive Additional Materials (DEFA14A).
IPERIONX Ltd 6-K neutral materiality 1/10

01-07-2026

IperionX Ltd filed a Form 6-K with the SEC on July 1, 2026, attaching a press release as Exhibit 99.1. The filing is a routine report of a foreign private issuer, signed by CFO Marcela Castro. No financial figures or operational details are disclosed in the filing itself.

INNSUITES HOSPITALITY TRUST 8-K negative materiality 9/10

01-07-2026

InnSuites Hospitality Trust (IHT) received a delisting notice from NYSE American on June 24, 2026, due to a stockholders' deficit of approximately $(921,921) as of April 30, 2026, and net losses in two of the three most recent fiscal years. The company must submit a compliance plan by July 24, 2026, and has until December 24, 2027, to regain compliance. While the notice does not immediately affect trading, a '.BC' indicator will be added to the ticker, and failure to meet the plan's terms could lead to delisting.

  • · The compliance plan deadline is July 24, 2026, and the cure period extends to December 24, 2027.
  • · A '.BC' below compliance indicator will be added to the IHT ticker five business days after the notice.
  • · The company is evaluating actions including conversion of RRF LLLP units and related-party debt into equity, capital raises, restructuring, and operational improvements.
NexGen Energy Ltd. 6-K neutral materiality 1/10

01-07-2026

NexGen Energy Ltd. filed a Form 6-K with the SEC on June 30, 2026, attaching a news release dated June 30, 2026. The filing is a routine foreign issuer report and does not contain any financial results or quantitative data.

Grupo Aval Acciones Y Valores S.A. 6-K neutral materiality 1/10

01-07-2026

Grupo Aval Acciones y Valores S.A. made a scheduled interest payment on its Sixth Issuance of Notes (denominated in Colombian Pesos) on June 30, 2026, as per the terms of the offering memorandum. This is a routine debt service obligation with no new financial or strategic implications for the company.

  • · The interest payment relates to the company's Sixth Issuance of Notes, which was issued in Colombian Pesos in the local market.
  • · The payment was made in accordance with the terms of the offering memorandum.
Prestige Wealth Inc. 6-K positive materiality 6/10

01-07-2026

Aurelion Inc. (formerly Prestige Wealth Inc.) announced a leadership transition effective June 30, 2026: Mr. Chang-Wei Chiu succeeds Mr. Moore Xin Jin as Chairman and Compensation Committee Chair, and Mr. Frank Zheng succeeds Mr. Björn Schmidtke as CEO. Mr. Tokihiko Shimizu was appointed as an independent director. The departures were not due to any disagreement. The new team brings deep digital assets and institutional investment experience, positioning the company for long-term growth.

  • · Mr. Chang-Wei Chiu holds a bachelor’s degree in business administration from the University of Southern California, specializing in mergers and acquisitions.
  • · Mr. Frank Zheng received a Bachelor’s degree in Finance from the University of Nottingham (2015), a Master’s from Northwestern University, and a Master’s from Hong Kong University of Science and Technology (2026).
  • · Mr. Tokihiko Shimizu is a certified pension actuary with nearly 20 years of experience and holds a Bachelor of Science in Mathematics from Sophia University (1987).
  • · The company's name changed from Prestige Wealth Inc. to Aurelion Inc. effective January 24, 2019.
Stewards, Inc. S-1/A mixed materiality 8/10

01-07-2026

Stewards, Inc. filed Amendment No. 5 to its S-1 registration statement on June 30, 2026, disclosing executive compensation details for fiscal years 2024 and 2025, including a one-time RSU grant of 250,000 shares each to six executives and directors. The company also implemented a leadership transition effective June 11, 2026, with Vincent Napolitano moving to Chairman Emeritus and Shaun Quin becoming CEO, alongside new employment agreements with increased base salaries and long-term incentives. However, the company is no longer actively pursuing a Nasdaq listing, and the RSUs remain unvested as of December 31, 2025, with no compensation expense recognized due to vesting conditions not deemed probable.

  • · The company is no longer actively pursuing a Nasdaq listing, and vesting conditions for RSUs may be revised or waived.
  • · No compensation expense was recognized for the RSU grant in 2025 because vesting conditions were not deemed probable as of December 31, 2025.
  • · Directors were not compensated during 2024 and through Q3 2025; compensation began in Q4 2025.
  • · The 2024 Equity Incentive Plan reserves 20,000,000 shares and expires August 21, 2034.
  • · New employment agreements effective June 1, 2026 include stock ownership guidelines (e.g., CEO: 6x base salary, CFO: 3x base salary).
  • · Severance for CEO is 2x base salary plus target bonus; for other executives, 1x base salary plus target bonus.
  • · Non-employee directors receive $30,000 annual cash retainer and $135,000 in RSUs annually.
  • · Glen Steward receives $592,200 annual cash retainer as Chairman of the Board.
MESOBLAST LTD 6-K neutral materiality 1/10

01-07-2026

Mesoblast Limited filed a press release with the Australian Securities Exchange on July 1, 2026, which was also furnished as an exhibit to its SEC Form 6-K. The filing itself does not disclose the content of the press release, so no financial or operational details are available from this document alone.

  • · The press release was filed with the ASX on July 1, 2026, and incorporated by reference into the SEC filing.
  • · The filing was signed by Paul Hughes, Company Secretary of Mesoblast Limited.
Largo Inc. 6-K neutral materiality 1/10

01-07-2026

Largo Inc. filed a Form 6-K with the SEC for June 2026, attaching a news release dated June 30, 2026. The filing was signed by Co-CEO Daniel Tellechea. No financial data or operational metrics were disclosed in the filing itself.

  • · Filing type: Form 6-K for the month of June 2026
  • · Exhibit 99.1: News Release dated June 30, 2026
  • · Commission File Number: 001-40333
Plum Acquisition Corp, IV DEFA14A neutral materiality 5/10

01-07-2026

Plum Acquisition Corp. IV filed a DEFA14A on July 1, 2026, announcing an extraordinary general meeting on July 10, 2026 to approve an extension of its business combination deadline to January 16, 2027 (or up to July 16, 2027 with monthly extensions). To reduce redemptions, the Sponsor plans to enter into non-redemption agreements with unaffiliated shareholders, offering Class B ordinary shares in exchange for not redeeming. However, the filing contains no financial results or performance metrics, and the extension signals the company has not yet completed a business combination, reflecting ongoing uncertainty.

  • · The deadline for shareholders to submit Class A ordinary shares for redemption is 5:00 p.m. Eastern time on July 8, 2026.
  • · The Sponsor and certain initial shareholders intend to convert substantially all of their Class B ordinary shares into Class A ordinary shares on a one-to-one basis, and those converted shares will not be entitled to trust account redemptions.
  • · The Sponsor currently holds 5,650,000 Class B ordinary shares and 1,010,000 Class A ordinary shares.
  • · The filing includes a form of Non-Redemption Agreement (Exhibit 10.1) detailing the assignment of Founder Shares to non-redeeming investors.
  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
Plum Acquisition Corp, IV 8-K neutral materiality 5/10

01-07-2026

Plum Acquisition Corp. IV filed an 8-K announcing an extraordinary general meeting on July 10, 2026, to approve an extension of its deadline to complete an initial business combination to January 16, 2027 (or up to July 16, 2027 with monthly extensions). To reduce redemptions, the Sponsor plans to enter into non-redemption agreements with unaffiliated shareholders, offering Class B ordinary shares as an incentive, and intends to convert substantially all of its Class B shares into Class A shares. The filing does not disclose specific financial figures or performance metrics, so no positive or negative trends can be identified.

  • · The deadline for Class A ordinary shareholders to submit redemption requests is 5:00 p.m. Eastern time on July 8, 2026.
  • · The Sponsor holds 5,650,000 Class B ordinary shares and 1,010,000 Class A ordinary shares.
  • · The Sponsor intends to convert substantially all Class B ordinary shares into Class A ordinary shares on a one-to-one basis, which will not be entitled to trust account redemptions.
  • · The form of Non-Redemption Agreement is filed as Exhibit 10.1.
Hartman vREIT XXI, Inc. 8-K neutral materiality 5/10

01-07-2026

Hartman vREIT XXI, Inc. announced that its Board of Directors determined an estimated net asset value (NAV) of $8.12 per share as of December 31, 2025, based on a portfolio of 10 wholly-owned commercial properties and an 83% tenant-in-common interest, totaling 861,177 square feet, along with a 2.47% interest in Hartman SPE and 1,258,406 shares/units of Silver Star Properties REIT. The NAV is derived from $75,064 thousand in net asset value attributable to common stockholders, with $93,571 thousand estimated fair value of real estate assets offset by $23,136 thousand in other net liabilities. The company cautions that the NAV is unaudited, does not reflect a liquidity discount, and actual realizable values may differ materially.

  • · The capitalization rate sensitivity analysis shows that if the weighted average cap rate of 5.5% increases by 2.5%, the estimated NAV per share would drop to $7.18; if it decreases by 2.5%, the NAV would rise to $10.25.
  • · Other assets and liabilities net to a negative $23,136 thousand, reducing the gross asset value by $2.50 per share.
  • · The estimated NAV does not include a liquidity discount for the fact shares are not traded on a national exchange, nor does it account for prepayment obligations or corporate overhead.
  • · The Company contributed its 48.8% interest in Three Forest Plaza (Dallas office property) to Hartman SPE in exchange for a 5.89% interest, later exchanging 3.42% of that interest for 700,302 shares of Silver Star common stock.
  • · As of December 31, 2025, the Company owned 1,258,406 shares of Silver Star common stock and operating partnership units, valued at $2.01 per share per Silver Star's reported NAV.
HIVE Digital Technologies Ltd. 8-K mixed materiality 8/10

01-07-2026

HIVE Digital Technologies Ltd. announced the pricing of a upsized US$115 million private offering of 0% exchangeable senior notes due 2031, increased from the previously announced US$100 million. The net proceeds of approximately US$110 million (or up to US$124.5 million if the initial purchasers' option is fully exercised) will be used for general corporate purposes, capital investment including GPU purchases, and data center development. The company also entered into capped call transactions to reduce potential dilution, with a cap price of US$8.5275 per share, representing a 125% premium to the closing price of US$3.79 on June 25, 2026.

  • · The notes will mature on July 1, 2031, unless earlier exchanged, redeemed or repurchased.
  • · Holders may require repurchase on July 1, 2030 at 100% of principal.
  • · Issuer may redeem notes on or after July 5, 2029 if stock price is at least 130% of exchange price for 20 trading days in a 30-day period.
  • · The offering is exempt from TSX shareholder approval under Section 602.1 for Eligible Interlisted Issuers.
  • · Option counterparties may engage in hedging activities that could affect the market price of common shares or notes.
AZUL SA 6-K neutral materiality 3/10

01-07-2026

Azul S.A. filed a Form 6-K with the SEC for June 2026, announcing the issuance of Subscription Warrants – Series 4. No financial figures or performance metrics were disclosed in this filing.

  • · Exhibit 99.1 details the Issuance of Subscription Warrants – Series 4
  • · Signed by Antonio Carlos Garcia, CFO of Azul S.A.
  • · Filing date: July 01, 2026; report for month ended June 30, 2026
BRAZILIAN ELECTRIC POWER CO 6-K neutral materiality 1/10

01-07-2026

AXIA Energia S.A. filed a Form 6-K with the SEC for June 2026, containing forward-looking statements and risk factors. The filing does not include any financial results or material operational updates.

Terra Innovatum Global N.V. 10-Q mixed materiality 8/10

01-07-2026

Terra Innovatum Global N.V. (NKLR) reported a net loss of $7.1M for Q1 2026, widening from a $1.4M loss in Q1 2025, driven by a $3.3M non-cash charge from a change in fair value of a share-settled contingent liability and a surge in operating expenses to $6.6M from $1.4M. However, the company ended the quarter with $96.7M in cash, up from just $44 a year ago, and recorded $2.8M in other income, reflecting a significant improvement in financial resources.

  • · General and administrative expenses rose to $5.4M in Q1 2026 from $1.4M in Q1 2025.
  • · Development costs increased to $1.2M in Q1 2026 from $33K in Q1 2025.
  • · Change in fair value of warrant liabilities was a gain of $83K in Q1 2026 (nil in Q1 2025).
  • · Net cash used in operating activities was $3.9M in Q1 2026 vs $199K in Q1 2025.
  • · Net cash used in investing activities was $328K in Q1 2026 (nil in Q1 2025), primarily for equipment purchases.
  • · No financing cash flows in Q1 2026; Q1 2025 had $172K from related party loans.
  • · Prepaid expenses and other current assets totaled $4.8M at March 31, 2026, up from $3.1M at December 31, 2025.
  • · Equipment, net was $417K at March 31, 2026 vs $102K at December 31, 2025.
  • · Accrued expenses and other current liabilities were $4.0M at March 31, 2026, up from $2.0M at December 31, 2025.
  • · Share-settled contingent liability decreased slightly to $185.9M at March 31, 2026 from $186.3M at January 1, 2026.
  • · Weighted average expected term for the contingent liability is 6.5 years; risk-free interest rate range 3.61% - 4.74%; dividend yield 0%.
  • · Accumulated deficit worsened to $(614.4M) at March 31, 2026 from $(607.3M) at January 1, 2026.
  • · Total shareholders' deficit was $(98.7M) at March 31, 2026 vs $(93.6M) at January 1, 2026.
Aptose Biosciences Inc. 8-K neutral materiality 10/10

01-07-2026

Aptose Biosciences Inc. was acquired by Hanmi Pharmaceuticals Co. Ltd. via a statutory plan of arrangement completed on June 30, 2026. Shareholders received C$2.41 per share in cash, with aggregate consideration of approximately USD$3.47M for 2,043,719 shares not already owned by Hanmi. All directors resigned, the stock will be delisted from the TSX, and the company will terminate its SEC reporting obligations.

  • · The arrangement was approved by the Court of King’s Bench of Alberta on March 31, 2026.
  • · Locust Walk Securities, LLC provided a fairness opinion to the Special Committee of the Board.
  • · Common shares are expected to be delisted from the TSX on or about July 3, 2026.
  • · The company will file a Form 15 to terminate or suspend its SEC reporting obligations.

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Pre-Market SEC Filings Roundup

June 23, 2026

US Pre-Market SEC Filings Roundup — June 23, 2026

June 22, 2026

US Pre-Market SEC Filings Roundup — June 22, 2026

June 19, 2026

US Pre-Market SEC Filings Roundup — June 19, 2026

June 18, 2026

US Pre-Market SEC Filings Roundup — June 18, 2026

🇺🇸 More from United States

View all →

June 23, 2026

New Drug Approvals (Original) — June 23, 2026

New Drug Approvals (Original)

June 23, 2026

Big Pharma Approvals — June 23, 2026

Big Pharma Approvals

June 23, 2026

NME Blockbuster Approvals — June 23, 2026

NME Blockbuster Approvals

June 23, 2026

Biotech Small-Cap Approvals — June 23, 2026

Biotech Small-Cap Approvals
← All United States digests